Suven Life Sciences Limited
Suven Life Sciences Limited, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1989, the company has established itself as a leader in drug discovery and development, focusing on central nervous system disorders and other therapeutic areas. With a robust portfolio of innovative products and services, Suven Life Sciences is renowned for its unique approach to developing novel compounds that address unmet medical needs. The company has achieved significant milestones, including successful collaborations and partnerships that enhance its market position. Operating primarily in India and expanding its reach globally, Suven Life Sciences continues to make strides in the industry, driven by a commitment to research excellence and patient-centric solutions.
DitchCarbon Score
How does Suven Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Suven Life Sciences Limited's score of 24 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Suven Life Sciences Limited's reported carbon emissions
In 2024, Suven Life Sciences Limited reported total carbon emissions of approximately 915,600 kg CO2e, comprising about 32,090 kg CO2e from Scope 1 and about 883,510 kg CO2e from Scope 2 emissions. In the previous year, 2023, the company recorded similar emissions, with approximately 30,540 kg CO2e from Scope 1 and about 858,080 kg CO2e from Scope 2, totalling around 888,620 kg CO2e. For 2022, emissions were reported at about 890,219 kg CO2e, with Scope 1 emissions at approximately 31,101 kg CO2e and Scope 2 emissions at about 859,118 kg CO2e. Notably, emissions data for 2025 is currently unavailable, indicating a lack of reported emissions for that year. Suven Life Sciences Limited has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The company is classified as a current subsidiary, and all emissions data is directly sourced from Suven Life Sciences Limited without any cascading from a parent organisation. Overall, while Suven Life Sciences Limited has made strides in tracking its carbon emissions, it currently lacks defined reduction targets or commitments to further mitigate its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 31,101 | 00,000 | 00,000 |
| Scope 2 | 859,118 | 000,000 | 000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Suven Life Sciences Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
